Literature DB >> 7427860

Intraoperative radiotherapy for advanced carcinoma of the biliary system.

T Todoroki, Y Iwasaki, T Okamura, K Nagoshi, H Asakura, M Nakano, T Inada, H Tsunemoto, Y Umegaki, A Nishimura, M Nakano, H Sato.   

Abstract

Since November 1973, intraoperative radiotherapy has been performed on five patients with unresectable, advanced carcinoma of the bile duct at the hepatic hilus and six patients with unresectable carcinoma of the gallbladder. A treatment cone with a diameter ranging from 4--10 cm was directly applied at the lesion. A single dose of 2500--3000 rad with 11 to 20 meV electrons was delivered. In all patients, recanalization of the obstructed bile duct was observed by the postoperative cholangiography. The local efficacy was confirmed histopathologically in eight autopsied materials and a specimen resected 105 days after radiotherapy. Mean survival time of patients with unresectable tumors was 10.9 +/- 5.6 (SD) months after this radiotherapy. Intraoperative radiotherapy increased the effectiveness and length of palliation for the unresectable lesion.

Entities:  

Mesh:

Year:  1980        PMID: 7427860     DOI: 10.1002/1097-0142(19801115)46:10<2179::aid-cncr2820461014>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma.

Authors:  T E Bowling; S M Galbraith; A R Hatfield; J Solano; M F Spittle
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

2.  Internal radiation for bile duct cancer.

Authors:  W C Meyers; R S Jones
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

3.  The role of intraoperative radiation therapy in the treatment of bile duct cancer.

Authors:  Y Iwasaki; T Todoroki; K Fukao; K Ohara; T Okamura; A Nishimura
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

4.  Radiotherapy of cholangiocarcinoma: the roles for primary and adjuvant therapies.

Authors:  T Shiina; S Mikuriya; T Uno; T Toita; S Serizawa; J Itami; S Kawai; M Tani
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  New advances in the management of biliary tract cancer.

Authors:  John Bridgewater; Charles Imber
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

6.  Intraoperative radiation therapy for carcinoma of the gallbladder.

Authors:  P M Busse; B Cady; A Bothe; R Jenkins; W V McDermott; G Steele; M D Stone
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

7.  Resection combined with intraoperative radiation therapy (IORT) for stage IV (TNM) gallbladder carcinoma.

Authors:  T Todoroki; Y Iwasaki; K Orii; M Otsuka; K Ohara; T Kawamoto; K Nakamura
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

8.  Biliary tract cancers in Cote-d'Or (France): incidence and natural history.

Authors:  P Renard; M C Boutron; J Faivre; C Milan; L Bedenne; P Hillon; C Klepping
Journal:  J Epidemiol Community Health       Date:  1987-12       Impact factor: 3.710

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.